Project Number 1R43AG058278-01A1 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Novel small molecules that target Alzheimers disease by increasing spinogenesis and decreasing A-beta toxicity Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator SIMMON, VINCENT Principal Investigator First Name VINCENT Principal Investigator Last Name SIMMON Awardee Organization SPINOGENIX, INC. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-17-064: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44) FY Overall Cost $314,511 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
